VC firm

Aisling Capital

7 investors · 7 verified

Here are all investors at Aisling Capital.

Investor preview

emails unlock with a plan

Investors on this list. Email addresses unlock with a plan.
namefirmemaillocationverified
Josh BilenkerPartnerAisling Capital1w ago
A.J SacksAnalystAisling CapitalUnited States3w ago
Stacey SeltzerPartnerAisling Capital3w ago
Eric AguiarPartnerAisling Capital4w ago
Dennis PurcellUnknownAisling Capital4w ago
Aftab KheraniPartnerAisling Capital4w ago
Dov GoldsteinManaging PartnerAisling Capital4w ago

Browse all VCs

Recent investments at Aisling Capital

  • Stratus TherapeuticsSeries B · $62M · 2023
  • Forge BiologicsSeries C · $90M · 2022
  • Dren BioSeries B · $65M · 2022
  • CellevolveSeed · $6M · 2021
  • Plant Culture SystemsPre Seed · $500K · 2021
  • Monte Rosa TherapeuticsSeries B · $96M · 2020
  • Eidos TherapeuticsSeries B · $64M · 2018
  • Bristol-Myers SquibbPost Ipo Equity · $80M · 2017
  • Zavante TherapeuticsSeries A · $45M · 2016
  • SpiroxSeries C · $45M · 2016
  • ViewRayPost Ipo Equity · $27M · 2015
  • Aimmune TherapeuticsSeries B · $80M · 2015

What founders say

4.1Based on 11 reviews